Dr. Hanna Taipaleenmäki is a group leader in the Molecular Skeletal Biology Laboratory (MSB-Lab) at the University Medical Center Hamburg-Eppendorf in Hamburg, Germany. During her PhD studies at the University of Turku, Finland, and at the Endocrine Research Unit, Odense University Hospital, Denmark, she developed a strong interest in post-transcriptional regulation of osteoblast differentiation and bone formation by non-coding RNAs. During her post-doctoral training at the University of Massachusetts Medical School, USA, and at the University Medical Center Hamburg-Eppendorf, Germany, she further elucidated the contribution of microRNAs in pathological bone remodeling with specific focus on cancer-induced bone disease. Currently her research group is investigating the role of osteoblasts in breast cancer-induced metastatic bone disease. Hanna is an active member of scientific societies including the ECTS and the ASBMR and her work has been awarded several awards, fellowships and grants.